Published in Am J Cardiol on April 22, 2008
Effects of repeated exposure to acceleration forces (+Gz) and anti-G manoeuvres on cardiac dimensions and performance. Exp Clin Cardiol (2010) 0.75
Left ventricular twist mechanics during incremental cycling and knee extension exercise in healthy men. Eur J Appl Physiol (2016) 0.75
Treatment and outcomes of acute basilar artery occlusion in the Basilar Artery International Cooperation Study (BASICS): a prospective registry study. Lancet Neurol (2009) 3.36
Markers of increased risk of intracerebral hemorrhage after intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke in clinical practice: the Multicenter rt-PA Stroke Survey. Circulation (2002) 2.71
Pretreatment with corticosteroids attenuates the efficacy of colchicine in preventing recurrent pericarditis: a multi-centre all-case analysis. Eur Heart J (2005) 2.47
Bezafibrate for the secondary prevention of myocardial infarction in patients with metabolic syndrome. Arch Intern Med (2005) 2.22
Functional class in patients with heart failure is associated with the development of diabetes. Am J Med (2003) 2.10
Efficacy of omega-3 fatty acid supplementation in primary and secondary prevention of coronary heart disease. Isr Med Assoc J (2004) 2.02
The metabolic syndrome entanglement: Cutting the Gordian knot. Cardiol J (2013) 2.01
Long-term changes in serum cholesterol level does not influence the progression of coronary calcification. Int J Cardiol (2010) 1.99
Comparison of magnesium status using X-ray dispersion analysis following magnesium oxide and magnesium citrate treatment of healthy subjects. Magnes Res (2012) 1.98
Renal dysfunction and risk of ischemic stroke or TIA in patients with cardiovascular disease. Neurology (2006) 1.65
Mortality and predictors of death 1 month and 3 years after first-ever ischemic stroke: data from the first national acute stroke Israeli survey (NASIS 2004). Neuroepidemiology (2009) 1.64
Perceptual, social, and behavioral factors associated with delays in seeking medical care in patients with symptoms of acute stroke. Stroke (2006) 1.63
Dual and pan-peroxisome proliferator-activated receptors (PPAR) co-agonism: the bezafibrate lessons. Cardiovasc Diabetol (2005) 1.61
Coronary calcium by spiral computed tomography predicts cardiovascular events in high-risk hypertensive patients. J Hypertens (2004) 1.57
Reduced incidence of ischemic stroke in patients with severe factor XI deficiency. Blood (2008) 1.57
Prevalence and clinical predictors of reverse remodeling in patients with dilated cardiomyopathy. Isr Med Assoc J (2014) 1.56
Ischemic stroke on awakening: patients' characteristics, outcomes and potential for reperfusion therapy. Neuroepidemiology (2012) 1.55
Second-hand tobacco smoke in never smokers is a significant risk factor for coronary artery calcification. JACC Cardiovasc Imaging (2013) 1.52
Impact of the metabolic syndrome on the clinical outcomes of non-clinically diagnosed diabetic patients with acute coronary syndrome. Am J Cardiol (2007) 1.50
Attenuation of progression of insulin resistance in patients with coronary artery disease by bezafibrate. Arch Intern Med (2006) 1.46
Calcification of the thoracic aorta as detected by spiral computed tomography among stable angina pectoris patients: association with cardiovascular events and death. Circulation (2008) 1.45
Exaggerated blood pressure response to exercise is not associated with masked hypertension in patients with high normal blood pressure levels. J Clin Hypertens (Greenwich) (2014) 1.43
Peroxisome proliferator-activated receptor ligand bezafibrate for prevention of type 2 diabetes mellitus in patients with coronary artery disease. Circulation (2004) 1.42
Effectiveness of establishing a dedicated acute stroke unit in routine clinical practice in Israel. Isr Med Assoc J (2005) 1.41
The prevalence and anatomical patterns of intramuscular coronary arteries: a coronary computed tomography angiographic study. J Am Coll Cardiol (2007) 1.40
Intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke: initial Israeli experience. Isr Med Assoc J (2004) 1.39
Pregnancy outcome following infections by coxsackie, echo, measles, mumps, hepatitis, polio and encephalitis viruses. Reprod Toxicol (2006) 1.38
Long-term association of brachial artery flow-mediated vasodilation and cardiovascular events in middle-aged subjects with no apparent heart disease. Int J Cardiol (2008) 1.31
Adiponectin: a manifold therapeutic target for metabolic syndrome, diabetes, and coronary disease? Cardiovasc Diabetol (2014) 1.31
Chronic kidney disease and clinical outcome in patients with acute stroke. Stroke (2009) 1.25
Interleukin-6 and the risk of future cardiovascular events in patients with angina pectoris and/or healed myocardial infarction. Am J Cardiol (2006) 1.17
Two-dimensional intraventricular flow mapping by digital processing conventional color-Doppler echocardiography images. IEEE Trans Med Imaging (2010) 1.17
The ubiquitous interleukin-6: a time for reappraisal. Cardiovasc Diabetol (2010) 1.16
Ischemic preconditioning: nearly two decades of research. A comprehensive review. Atherosclerosis (2004) 1.15
Fasting plasma glucose and risk of incident ischemic stroke or transient ischemic attacks: a prospective cohort study. Stroke (2004) 1.15
Colchicine for the prevention of postpericardiotomy syndrome. Herz (2002) 1.13
Spiral computed tomography evidence of close correlation between coronary and thoracic aorta calcifications. Atherosclerosis (2004) 1.11
A risk score to predict intracranial hemorrhage after recombinant tissue plasminogen activator for acute ischemic stroke. J Stroke Cerebrovasc Dis (2008) 1.11
Metabolic syndrome and type 2 diabetes mellitus: focus on peroxisome proliferator activated receptors (PPAR). Cardiovasc Diabetol (2003) 1.10
Fibrates are an essential part of modern anti-dyslipidemic arsenal: spotlight on atherogenic dyslipidemia and residual risk reduction. Cardiovasc Diabetol (2012) 1.10
Effect of bezafibrate on incidence of type 2 diabetes mellitus in obese patients. Eur Heart J (2005) 1.09
Effects of peroxisome proliferator-activated receptor ligands, bezafibrate and fenofibrate, on adiponectin level. Arterioscler Thromb Vasc Biol (2006) 1.09
Cardiovascular diabetology in the core of a novel interleukins classification: the bad, the good and the aloof. Cardiovasc Diabetol (2003) 1.09
"The metabolic syndrome... is dead": these reports are an exaggeration. Cardiovasc Diabetol (2011) 1.08
Salvaging brain: new concepts in the management of acute stroke. Isr Med Assoc J (2004) 1.08
Current smoking, smoking cessation, and the risk of sudden cardiac death in patients with coronary artery disease. Arch Intern Med (2003) 1.07
Poor nutritional habits are predictors of poor outcome in very old hospitalized patients. Am J Clin Nutr (2005) 1.05
Chronic kidney disease in patients with acute intracerebral hemorrhage: association with large hematoma volume and poor outcome. Cerebrovasc Dis (2010) 1.04
Systemic dysregulation of CEACAM1 in melanoma patients. Cancer Immunol Immunother (2010) 1.02
Admission blood glucose level and mortality among hospitalized nondiabetic patients with heart failure. Arch Intern Med (2006) 1.01
Prior use of statins improves outcome in patients with intracerebral hemorrhage: prospective data from the National Acute Stroke Israeli Surveys (NASIS). Stroke (2009) 1.00
Coronary calcium in patients with and without diabetes: first manifestation of acute or chronic coronary events is characterized by different calcification patterns. Cardiovasc Diabetol (2013) 1.00
Soluble intercellular adhesion molecule-1 and long-term risk of acute coronary events in patients with chronic coronary heart disease. Data from the Bezafibrate Infarction Prevention (BIP) Study. J Am Coll Cardiol (2002) 0.99
Insulin resistance is associated with increased risk of major cardiovascular events in patients with preexisting coronary artery disease. Am Heart J (2007) 0.99
Hospital disposition after stroke in a national survey of acute cerebrovascular diseases in Israel. Arch Phys Med Rehabil (2008) 0.98
Balanced pan-PPAR activator bezafibrate in combination with statin: comprehensive lipids control and diabetes prevention? Cardiovasc Diabetol (2012) 0.98
Atherogenic dyslipidemia in metabolic syndrome and type 2 diabetes: therapeutic options beyond statins. Cardiovasc Diabetol (2006) 0.95
A cardiologic approach to non-insulin antidiabetic pharmacotherapy in patients with heart disease. Cardiovasc Diabetol (2009) 0.95
Educational level as a modulator of cognitive performance and neuropsychyatric features in Parkinson disease. Cogn Behav Neurol (2007) 0.94
Macrovascular complications of metabolic syndrome: an early intervention is imperative. Int J Cardiol (2004) 0.93
Is hypoglycaemia a marker for increased long-term mortality risk in patients with coronary artery disease? An 8-year follow-up. Eur J Cardiovasc Prev Rehabil (2004) 0.93
Cardiovascular events in patients received combined fibrate/statin treatment versus statin monotherapy: Acute Coronary Syndrome Israeli Surveys data. PLoS One (2012) 0.93
Homocysteine, B-vitamin supplementation, and stroke prevention: from observational to interventional trials. Lancet Neurol (2004) 0.93
Extra-cardiac findings on coronary computed tomography scanning. Isr Med Assoc J (2008) 0.92
Body height is associated with decreased long-term stroke but not coronary heart disease mortality? Stroke (2002) 0.92